| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 03/02/2006 | WO2006021652A1 Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives |
| 03/02/2006 | WO2006021213A2 Vasopressin v1a antagonists |
| 03/02/2006 | WO2005103010A3 Pyrazole derivatives useful for the treatment of cancer |
| 03/02/2006 | WO2005079774A3 Management of ophthalmologic disorders, including macular degeneration |
| 03/02/2006 | US20060047126 e.g. 3-[1-(2,4-dichlorobenzyl)-6-trifluoromethyl-1H-indazol-3-yl]-acrylic acid; anticarcinogenic agent; inhibitors of spermatogenesis, heat shock proteins and/or elongation factor 1 alpha; analogues of lonidamine |
| 03/02/2006 | DE102004041531A1 Verfahren zum Herstellen von Biphenylaminen A method for producing biphenyl amines |
| 03/02/2006 | CA2577837A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | CA2577420A1 Lonidamine analogues and their use in male contraception and cancer treatment |
| 03/02/2006 | CA2577089A1 Sigma receptor inhibitors |
| 03/02/2006 | CA2564223A1 Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives |
| 03/01/2006 | EP1630164A1 Pyrazolopyrimidinones as phosphodiesterase inhibitors |
| 03/01/2006 | EP1628963A1 Novel ureido - and amido-pyrazolone derivatives |
| 03/01/2006 | EP1628962A1 Iodopyrazolyl carboxanilides |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
| 03/01/2006 | CN1742013A Pyrazolopyrimidine compound and method for producing the same |
| 03/01/2006 | CN1740179A N4-substituent pyrazolyl [4,5-e][1,2,4] thiadiazine derivative and its prepn process and medicine composition |
| 03/01/2006 | CN1740162A Process for the preparation of pesticidal compounds |
| 03/01/2006 | CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/23/2006 | WO2005123688A3 3-aminoindazoles |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | US20060041095 Intermediate products, methods for their preparation and use thereof |
| 02/23/2006 | US20060040973 Novel guanidine mimics as factor Xa inhibitors |
| 02/23/2006 | DE102004039280A1 1,5-Diphenyl-pyrazole 1,5-diphenyl-pyrazoles |
| 02/23/2006 | CA2576531A1 1,5-diphenylpyrazoles |
| 02/23/2006 | CA2574078A1 Ophthalmic compositions for treating ocular hypertension |
| 02/22/2006 | EP1627877A1 Processes for producing pyrazoloacridone derivative and intermediate therefor |
| 02/22/2006 | EP1626967A1 Substituted pyrazoles |
| 02/22/2006 | EP1626963A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 02/22/2006 | EP1626962A1 Benzamide inhibitors of the p2x7 receptor |
| 02/22/2006 | EP1121431B1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2006 | CN1738804A 吡唑化合物 Pyrazole compounds |
| 02/21/2006 | US7002023 Method for producing 1 substituted 5-chloro-4 methly pyrazoles |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/16/2006 | WO2006017384A2 Indazoles useful in treating cardiovascular diseases |
| 02/16/2006 | WO2006015860A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 02/16/2006 | WO2005121097A3 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
| 02/16/2006 | US20060035934 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| 02/16/2006 | US20060035110 Electroluminescent materials and devices |
| 02/16/2006 | CA2576407A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/16/2006 | CA2576254A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 02/16/2006 | CA2575180A1 Indazoles useful in treating cardiovascular diseases |
| 02/16/2006 | CA2572752A1 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 02/16/2006 | CA2572745A1 Pyrazole amide derivatives, compositions containing such compounds and methods of use |
| 02/15/2006 | CN1735614A Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
| 02/15/2006 | CN1241915C Prepn process and use of substituted pyrazole compound |
| 02/14/2006 | US6998489 Methods of making indazoles |
| 02/14/2006 | US6998415 Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| 02/14/2006 | US6998414 Substituted arylamides as IP antagonists |
| 02/09/2006 | WO2006014290A2 Anti-inflammatory medicaments |
| 02/09/2006 | WO2006014134A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030612 2-Benzyl-3-(4-methoxyphenyl)-7-trifluoromethyl-2h-indazole; 3-[4-(2-benzyl-7-trifluoromethyl-2h-indazol-3-yl)-benzyl]-benzoic acid methyl ester, for example; useful in the treatment or inhibition of LXR (Liver X receptor) mediated diseases, e.g., cardiovascular diseases |
| 02/09/2006 | CA2576073A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | CA2573124A1 Anti-inflammatory medicaments |
| 02/08/2006 | EP1623741A2 Cannabinoid receptor ligands for hair growth modulation |
| 02/08/2006 | EP1622904A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622892A1 Indazoles having analgesic activity |
| 02/08/2006 | EP1622890A2 Blockers of the quorum sensing system of gram-negative bacteria |
| 02/08/2006 | EP1622876A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
| 02/08/2006 | EP1622866A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1309328A4 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 02/08/2006 | EP1149082B1 Process for preparing pesticidal intermediates |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732158A Indazole derivatives as CRF antagonists |
| 02/08/2006 | CN1732157A 1-alkyl-3-aminoindazoles |
| 02/08/2006 | CN1732156A Biphenyl derivatives and their use as fungicides |
| 02/08/2006 | CN1732155A 4-amino-5-methylpyrazole derivatives and process for production thereof |
| 02/08/2006 | CN1731994A Prophylactic and therapeutic agent for neuropathy |
| 02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995178 Insecticidal anthranilamides |
| 02/02/2006 | WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | WO2006011005A1 Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents |
| 02/02/2006 | WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/02/2006 | WO2005110994A3 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
| 02/02/2006 | US20060025467 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
| 02/02/2006 | US20060025466 E.g., N-[1-cyano-1-methyl-2-(5-nitroindazol-1-yl)-ethyl]-4-trifluoromethoxybenzamide; especially suitable for controlling parasites such as helminthes on warm-blooded animals. |
| 02/02/2006 | US20060025454 Prenylation inhibitors and methods of their synthesis and use |
| 02/02/2006 | US20060025448 Hair growth stimulators |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/02/2006 | DE102004033021A1 Liquid pressure transmitting medium, useful in hydraulic component or machines, comprises ionic liquid as pressure transmitting medium |
| 02/02/2006 | CA2578332A1 Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents |
| 02/02/2006 | CA2574460A1 High stability diionic liquid salts |
| 02/02/2006 | CA2574313A1 Inhibitors of hsp90 |
| 02/02/2006 | CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/01/2006 | EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/01/2006 | EP1620412A2 Heterocyclic compounds and hydro isomers thereof |
| 02/01/2006 | EP1620405A2 Pyrazole-amides and sulfonamides as sodium channel modulators |
| 02/01/2006 | EP1620108A2 Pyrazole-amine compounds useful as kinase inhibitors |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | EP1620090A1 Pyrazole compounds as hsp90 inhibitors for the treatment of cancer |